06978 IMMUNOTECH-B 永泰生物－Ｂ - Free Real Time Stock Quote- SDI Shareholder disclosure of interest

繁體版／简体版 | Set Homepage | Switch Color

Stocks Futures Warrants / CBBC ETF HK GoGoGo

06978 IMMUNOTECH-B

Nominal

1.730 -0.140 (-7.487%)

Income Statement (Profit & Loss)

Financial Position (Balance Sheet)

Cash Flow Statement

Profit Estimation

Shareholder's Disclosure of Interests

Disclosure of Interest ｜ Fund Raising ｜ Share Repurchase

Date	Shareholder name	Reason of Disclosure	Buy/Sell and Involved Shares	Average Price per share	Current Holdings	% of Issued Shares
04/08/2024	China Resources Pharmaceutical Group Limited	1711(L)	+165,595,721(L)		217,054,121(L)	42.18
04/08/2024		1711(L)	+165,595,721(L)		165,595,721(L)	32.18
04/08/2024	China Resources Company Limited	1711(L)	+165,595,721(L)		217,054,121(L)	42.18
11/04/2023	Evodevo LTD	1304(S)	-90,128,571(S)		44,820,000(L)	8.71
11/04/2023	Jung Hyun Chul	1304(S)	-90,128,571(S)		44,820,000(L)	8.71
31/03/2023		1303(L)	90,128,571(L)		191,595,721(L)	37.23
31/03/2023		1303(L)	90,128,571(L)		191,595,721(L)	37.23
31/03/2023	Yan Kaijing	1303(L)	90,128,571(L)		191,595,721(L)	37.23
31/03/2023		1303(L)	90,128,571(L)		191,595,721(L)	37.23
31/03/2023		1303(L)	90,128,571(L)		191,595,721(L)	37.23
31/03/2023	Tasly (Hong Kong) Pharmaceutical Investment Limited	1303(L)	90,128,571(L)		191,595,721(L)	37.23
31/03/2023		1303(L)	90,128,571(L)		191,595,721(L)	37.23
31/03/2023		1303(L)	90,128,571(L)		191,595,721(L)	37.23
31/03/2023		1303(L)	90,128,571(L)		191,595,721(L)	37.23
31/03/2023		1303(L)	90,128,571(L)		191,595,721(L)	37.23
31/03/2023		1303(L)	90,128,571(L)		191,595,721(L)	37.23
31/03/2023	Yan Xijun	1303(L)	90,128,571(L)		191,595,721(L)	37.23
31/03/2023		1303(L)	90,128,571(L)		191,595,721(L)	37.23
31/03/2023		1303(L)	90,128,571(L)		191,595,721(L)	37.23
31/03/2023	Li Yunhui	1303(L)	90,128,571(L)		191,595,721(L)	37.23
31/03/2023		1303(L)	90,128,571(L)		191,595,721(L)	37.23
31/03/2023	Wu Naifeng	1303(L)	90,128,571(L)		191,595,721(L)	37.23
20/02/2023		1205(L)	-51,480,000(L)		191,595,721(L)	37.23
20/02/2023		1205(L)	-51,480,000(L)		191,595,721(L)	37.23
20/02/2023	Tan Zheng	1316(L)	19,285,714(L)		185,480,000(L)	36.04
20/02/2023		1205(L)	-51,480,000(L)		191,595,721(L)	37.23
20/02/2023		1205(L)	-51,480,000(L)		191,595,721(L)	37.23
20/02/2023		1205(L)	-51,480,000(L)		191,595,721(L)	37.23
20/02/2023		1205(L)	-51,480,000(L)		191,595,721(L)	37.23
20/02/2023		1205(L)	-51,480,000(L)		191,595,721(L)	37.23
20/02/2023		1205(L)			191,595,721(L)	37.23
20/02/2023		1205(L)	-51,480,000(L)		191,595,721(L)	37.23
20/02/2023	Tasly (Hong Kong) Pharmaceutical Investment Limited	1205(L)	-51,480,000(L)		191,595,721(L)	37.23
20/02/2023		1205(L)	-51,480,000(L)		191,595,721(L)	37.23
20/02/2023		1205(L)	-51,480,000(L)		191,595,721(L)	37.23
20/02/2023		1205(L)	-51,480,000(L)		191,595,721(L)	37.23
20/02/2023		1205(L)	-51,480,000(L)		191,595,721(L)	37.23
20/02/2023		1205(L)			191,595,721(L)	37.23
20/02/2023	Tan Yueyue	1316(L)	6,714,286(L)		59,794,286(L)	11.62
20/02/2023		1205(L)	-51,480,000(L)		191,595,721(L)	37.23

1 2

Remark:	(L) - Long Position, (S) - Short Position, (P) Lending;
	Real time quote last updated: 18/11/2024 16:18
	Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service

A Member of HKET Holdings

Customer Service Hotline:(852) 2880 7004 Customer Service Email:cs@etnet.com.hk

Security Tips

Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.